This report outlines the microbiology strategy as well as actions, outcome indicators and performance targets for the delivery and evaluation of its execution over the period 2018–2022.
This report for 2016, which presents the indicator results for EU and EEA (European Economic Area) countries, aims to help policymakers identify possible areas for action and to evaluate the impact of capacity strengthening activities and health system reforms.
ECDC’s report EU Laboratory Capability (EULabCap) published on the 30th of April, based on the results of the 2016 survey, concludes that the EU/EEA can rely in a public health microbiology system with strong overall capabilities and substantial capacity to fulfil EU surveillance and response.
This rapid risk assessment update appraises the risk for spread of C. auris in hospitals in the European Union and European Economic Area (EU/EEA) countries
The rise in Europe of Candida auris infections, a difficult-to-control fungus, is of concern. The fungus spreads easily in healthcare settings, can cause invasive infections, and is also associated with resistance to multiple classes of anti-fungal medication.
Overall aim of this regional ENLabCap consultation workshop was to discuss the adjustments proposed to the current EULabCap tool and agree on those needed to adapt it for the EU enlargement countries.